Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Record Number of Jews Visit Temple Mount on Tisha B’Av Just Before Gates Slammed Shut

On Sunday, on the holy day of Tisha B’Av, Yeraeh, a Temple…
Read more

Musk’s Plan to Connect The World at The Speed of Light

Starlink will soon be able to support competitive online…
Read more

European States Restricting Ability of Unvaccinated to Live Normal Lives

Greece became the latest to enact new restrictions on Friday,…
Read more